Upgrading cell and gene therapy “software” for safety; Pharma picks their PROTAC horses; The first healthtech giant; and more Upgrading cell and gene therapy “software” for safety; Pharma picks their PROTAC horses; The first healthtech giant; and more by a16z editorial, Andy Tran, and Judy Savitskaya